Maso Capital Partners’s New Frontier Health Corporation Ordinary Shares NFH Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2022
Q2
Sell
-3,054,062
Closed -$36.6M 77
2022
Q1
$36.6M Hold
3,054,062
14.91% 3
2021
Q4
$35M Sell
3,054,062
-245,080
-7% -$2.76M 16.08% 2
2021
Q3
$37M Sell
3,299,142
-380,163
-10% -$4.24M 16.69% 3
2021
Q2
$41.1M Buy
3,679,305
+1,780,368
+94% +$20M 13.5% 2
2021
Q1
$21.5M Buy
1,898,937
+1,198,937
+171% +$12.2M 8.27% 3
2020
Q4
$6.02M Hold
700,000
1.64% 7
2020
Q3
$5.34M Hold
700,000
2.99% 6
2020
Q2
$5.8M Hold
700,000
2.34% 5
2020
Q1
$5.78M Hold
700,000
1.5% 9
2019
Q4
$7M Hold
700,000
2.25% 11
2019
Q3
$7.13M Buy
+700,000
New +$7.12M 2.56% 11

Maso Capital Partners's NFH Position: Q2 2022 in Review

Maso Capital Partners sold out of New Frontier Health Corporation Ordinary Shares (NFH) in Q2 2022, closing a stake of 3,054,062 shares — an estimated $36.6M sold.

Maso Capital Partners first reported a position in NFH in Q3 2019 and held it in 11 quarters. The position peaked at $41.1M in Q2 2021. 0 funds tracked by Wall St. Rank hold NFH as of Q2 2022.

  • Maso Capital Partners reported no remaining New Frontier Health Corporation Ordinary Shares position as of Q2 2022 after selling out during the quarter.
  • Maso Capital Partners sold 3,054,062 New Frontier Health Corporation Ordinary Shares shares in Q2 2022, an estimated $36.6M.
  • Maso Capital Partners first reported a position in New Frontier Health Corporation Ordinary Shares in Q3 2019 and held it in 11 quarters.
  • Maso Capital Partners's New Frontier Health Corporation Ordinary Shares position peaked at $41.1M in Q2 2021.
  • 0 funds tracked by Wall St. Rank held New Frontier Health Corporation Ordinary Shares as of Q2 2022.

Based on Maso Capital Partners's 13F filing for Q2 2022, filed 15 Aug 2022.